model: gpt-4-1106-preview
prompt: Write a paragraph of text in the style of a biomedical research article. Include the following protein complex name: Intrinsic tenase. Use this name exactly as provided, avoiding any synonyms, aliases, abbreviated or expanded forms. Also avoid including any other names referring to a gene, protein, protein complex, protein part or component, or any other molecular entity containing amino acid residues. The text can include mentions of other biomedical entity types, such as chemical, organism, and disease names.
output: The Intrinsic tenase complex plays a pivotal role in the coagulation cascade that mediates hemostasis in mammalian organisms. Recent studies have investigated the specific pharmacodynamics of novel anticoagulant agents that target the activity of Intrinsic tenase, with the intention of preventing thrombus formation in pathological conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). The efficacy of these agents was assessed using an in vitro coagulometry assay, which quantified the time to clot formation in human plasma samples following the addition of activated Intrinsic tenase. The results indicated a dose-dependent prolongation of clotting time, suggesting that the inhibition of Intrinsic tenase can significantly impede the progression of the coagulation cascade. Furthermore, in vivo experiments conducted on rodent models of induced thrombosis revealed that the systemic administration of these inhibitors reduced the incidence of vessel occlusion without markedly increasing bleeding risk, thus emphasizing the therapeutic potential of selectively targeting Intrinsic tenase. These outcomes not only elucidate the mechanistic implications of Intrinsic tenase within the intrinsic pathway of coagulation but also underscore the promise of targeted anticoagulants in the management of thromboembolic disorders.
